Title : mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy - Weiler_2014_Proc.Natl.Acad.Sci.U.S.A_111_409 |
Author(s) :
Weiler M , Blaes J , Pusch S , Sahm F , Czabanka M , Luger S , Bunse L , Solecki G , Eichwald V , Jugold M , Hodecker S , Osswald M , Meisner C , Hielscher T , Rubmann P , Pfenning PN , Ronellenfitsch M , Kempf T , Schnolzer M , Abdollahi A , Lang F , Bendszus M , von Deimling A , Winkler F , Weller M , Vajkoczy P , Platten M , Wick W |
Ref :
Proc Natl Acad Sci U S A , 111 :409 , 2014 |
Abstract :
|
PubMedSearch : Weiler_2014_Proc.Natl.Acad.Sci.U.S.A_111_409 |
PubMedID: 24367102 |